Chemoradiotherapy laryngeal preservation for advanced hypopharyngeal cancer

Japanese Journal of Clinical Oncology

Volumn 38, Issue 8, 2008, Pages 521-527

  Tai, Shyh Kuan ^a,b   Yang, Muh Hwa ^a,b   Wang, Ling Wei ^a,b   Tsai, Tung Lung ^a,b   Chu, Pen Yuan ^a   Wang, Yi Feng ^a   Huang, Jui Lin ^a   Chang, Shyue Yih ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Chemotherapy; Hypopharyngeal cancer; Laryngeal preservation; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; METHOTREXATE;

ACUTE KIDNEY FAILURE; ADULT; ADVANCED CANCER; AGED; AIRWAY OBSTRUCTION; ALCOHOL WITHDRAWAL; ANEMIA; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DEHYDRATION; DISEASE FREE SURVIVAL; DRUG DOSE REGIMEN; DRUG FATALITY; FEMALE; HUMAN; HUMAN TISSUE; HYPOPHARYNX CANCER; LARYNGEAL BIOPSY; LYMPHADENOPATHY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; OPTIMAL DRUG DOSE; OVERALL SURVIVAL; PATIENT CARE; PATIENT MONITORING; PROGNOSIS; RETROSPECTIVE STUDY; SEPSIS; SKIN MANIFESTATION; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; TRACHEOSTOMY; TUBE FEEDING; VOMITING; FOLLOW UP; HYPOPHARYNX TUMOR; LARYNX; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; SURVIVAL RATE; TREATMENT OUTCOME; X RAY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNX; MALE; METHOTREXATE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; X-RAYS;

EID: 51649085623     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyn073     Document Type: Article

References (30)

1. Hoffman HT, Karnell LH, Funk GF, Robinson RA, Menck HR. The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg 1998;124:951-62.
2. Hoffman HT, Karnell LH, Shah JP, Ariyan S, Brown GS, Fee WE, et al. Hypopharyngeal cancer patient care evaluation. Laryngoscope 1997;107:1005-17.
3. Bova R, Goh R, Poulson M, Coman WB. Total pharyngolaryngectomy for squamous cell carcinoma of the hypopharynx: A review. Laryngoscope 2005;115:864-9.
4. Chu PY, Wang LW, Chang SY. Surgical treatment of squamous cell carcinoma of the hypopharynx: Analysis of treatment results, failure patterns, and prognostic factors. J Laryngol Otol 2004;118:443-9.
5. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991;324:1685-90.
6. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 1996;88:890-9.
7. Adelstein DJ, Li Y, Adams GL, Wagner H, Jr, Kish JA, Ensley JF, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003;21:92-8.
8. Vokes EE, Kies MS, Haraf DJ, Stenson K, List M, Humerickhouse R. et al. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. J Clin Oncol 2000;18:1652-61.
9. Altundag O, Gullu I, Altundag K, Yalcin S, Ozyar E, Cengiz M, et al. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: Results of single-center study of 45 patients. Head Neck 2005;27:15-21.
10. Shin DM, Glisson BS, Khuri FR, Lippman SM, Ginsberg L, Diaz E, Jr, et al. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck. Cancer 2002;95: 322-30.
11. Urba SG, Wolf GT, Bradford CR, Thornton AF, Eisbruch A, Terrell JE, et al. Neoadjuvant therapy for organ preservation in head and neck cancer. Laryngoscope 2000;110:2074-80.
12. Adelstein DJ, Saxton JP, Rybicki LA, Esclamado RM, Wood BG, Strome M, et al. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: Mature results from a single institution. J Clin Oncol 2006;24:1064-71.
13. Urba SG, Moon J, Giri PG, Adelstein DJ, Hanna E, Yoo GH, et al. Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: A Southwest Oncology Group Trial. J Clin Oncol 2005;23:88-95.
14. Vokes EE, Stenson K, Rosen FR, Kies MS, Rademaker AW, Witt ME, et al. Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracill and hydroxyurea chemoradiotherapy: Curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol 2003;21:320-6.
15. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, et al. AJCC cancer staging manual. 6th edn. New York, NY: Springer 2002.
16. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-16.
17. Adelstein DJ, Leblanc M. Does induction chemotherapy have a role in the management of locoregionally advanced squamous cell head and neck cancer? J Clin Oncol 2006;24:2624-8.
18. Amdur RJ, Mendenhall WM, Stringer SP, Villaret DB, Cassisi NJ. Organ preservation with radiotherapy for T1-T2 carcinoma of the pyriform sinus. Head Neck 2001;23:353-62.
19. Garden AS, Morrison WH, Clayman GL, Ang KK, Peters LJ. Early squamous cell carcinoma of the hypopharynx: Outcomes of treatment with radiation alone to the primary disease. Head Neck 1996;18: 317-22.
20. Nakamura K, Shioyama Y, Sasaki T, Ohga S, Saku M, Urashima Y, et al. Chemoradiation therapy with or without salvage surgery for early squamous cell carcinoma of the hypopharynx. Int J Radiat Oncol Biol Phys 2005;62:680-3.
21. Lee WT, Akst LM, Adelstein DJ, Saxton JP, Wood BG, Strome M, et al. Risk factors for hypopharyngeal/upper esophageal stricture formation after concurrent chemoradiation. Head Neck 2006;28: 808-12.
22. Hanna E, Alexiou M, Morgan J, Badley J, Maddox AM, Penagaricano J, et al. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations. Arch Otolaryngol Head Neck Surg 2004;130:861-7.
23. Crehange G, Maingon P, Peignaux K, N'Guyen T D, Mirabel X, Marchal C, et al. Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: Federation Francophone de Cancerologie Digestive 9102. J Clin Oncol 2007;25:4895-901.
24. Fujiwara Y, Kamikonya N, Inoue T, Koishi K, Yoshikawa R, Nakao K, et al. Chemoradiotherapy for T3 and T4 squamous cell carcinoma of the esophagus using low-dose FP and radiation: A preliminary report. Oncol Rep 2005;14:1177-82.
25. Shimoyama S, Konishi T, Kawahara M, Kaminishi M, Ito A, Hojo K, et al. Pre-operative chemoradiation therapy with 5-fluorouracil and low-dose daily cisplatin for esophageal cancer: A preliminary report. Jpn J Clin Oncol 1999;29:132-6.
26. Fountzilas G, Tolis C, Kalogera-Fountzila A, Misailidou D, Tsekeris P, Karina M, et al. Paclitaxel, cisplatin, leucovorin, and continuous infusion fluorouracil followed by concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the head and neck: A Hellenic Cooperative Oncology Group Phase II Study. Med Oncol 2005;22:269-79.
27. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091-8.
28. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000;355:949-55.
29. Adelstein DJ, Saxton JP, Lavertu P, Tuason L, Wood BG, Wanamaker JR, et al. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results. Head Neck 1997;19:567-75.
30. Pfister DG, Ridge JA. Induction chemotherapy for larynx preservation: patient selection or therapeutic effect? J Clin Oncol 2006;24:540-3.